Of interest, several sgRNAs targeting the NKX3.1 gene were depleted in the LNCaP_FGC CRISPR screen, suggesting that loss of NKX3.1 is detrimental to prostate carcinoma survival or growth (Figure 9A). Here, NKX3-1 is linked to prostate carcinoma.